Navigation Links
Optogenetic tool elucidated

Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision. The key tool of optogenetics is the light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin have now succeeded in explaining the switching mechanism through an interdisciplinary approach. The researchers report on their findings in the Journal of Biological Chemistry.

Redistribution of water molecules

Until now, little has been known about the mechanism of the protein - especially about how the channel opens. However, deeper understanding is a prerequisite in order to be able to use the light-controlled protein specifically for neurobiological applications. In a new, multi-disciplinary approach, the Bochum scientists led by Prof. Dr. Klaus Gerwert (Department of Biophysics at the RUB) and their cooperation partners in Berlin have been able to shed light on the switching mechanism. The result: the light-induced change in the charge state of amino acid glutamate 90 (E90) triggers an increased penetration of water molecules, so that the protein can now purposefully conduct ions through the cell membrane.

Three methods combined

Using time-resolved infrared spectroscopy, the RUB biophysicists Jens Kuhne and Dr. Erik Freier have been able to show for the first time that the channel is opened through the deprotonation of the amino acid glutamate 90 (E90). In addition, the electrophysiological experiments of the researchers in Berlin confirm that a mutation of the amino acid leads to a change in the ion permeability of the protein. Instead of using safety goggles and lab coats, the two biophysicists Kirstin Eisenhauer and Dr. Steffen Wolf at the Department of Biophysics used supercomputers to simulate how the protonation change of the glutamate opens the channel and allows water molecules to penetrate.

Internationally preeminent

The work has attained particular distinction right now, because shortly after the Bochum pre-publication on the Internet, Japanese researchers published the three-dimensional structure of a channelrhodopsin online in "Nature". "The structure work impressively confirms our biomolecular simulations and the key role played by the amino acid E90 in the switching of the channel", says Prof. Klaus Gerwert. "We are therefore particularly proud to have been preeminent in this internationally competitive field." In 2010, optogenetics was distinguished by "Nature Methods" as the "Method of the Year". Using this method, researchers have succeeded, for example, in restoring the eyesight of blind mice.


Contact: Dr. Klaus Gerwert
Ruhr-University Bochum

Related biology news :

1. Light workout: Stanford scientists use optogenetics to effectively stimulate muscle movement in mice
2. The leading edge of stress: New genomic, optogenetic and epigenetic findings
3. Connection elucidated between obesity, salt sensitivity and high blood pressure
4. A new signaling pathway of the immune system is elucidated
Post Your Comments:
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, ... today that it has signed a contract with the ... across the full range of sentences under the Department,s ... of the Americas. "This contract with the Virginia DOC ... the US and advances our position as a trusted ...
(Date:10/5/2015)... ) releases ... (NASDAQ: NXTD ), a biometric authentication company focused ... ) releases the following market and ... a biometric authentication company focused on the growing mobile ... ) releases the following market and ...
(Date:10/1/2015)... Oct. 1, 2015  Biometrics includes diverse set ... body characteristics, such as fingerprints, eye retinas, facial ... of biometrics technology has been constantly increasing in ... five years. In addition to the most prominent ... recognition, other means of biometric authentication are rapidly ...
Breaking Biology News(10 mins):
(Date:10/12/2015)... Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... engaged in developing and commercializing novel treatments in oncology, ... Dennis Turpin , the Company,s former Senior Vice ... its Quebec City office.  ... Chief Executive Officer of the Company commented, "After a ...
(Date:10/12/2015)... October 12, 2015 LabStyle Innovations ... Management Solution, today announced its Medical Director, Dr. ... at MobiHealth,s 5th EAI International Conference on Wireless ... through innovations in mobile and wireless technologies," the conference ... from October 14 - 16, 2015. The conference ...
(Date:10/12/2015)... , Oct. 12, 2015 VolitionRx Limited ... a completed clinical study of its NuQ ® blood-based ... the online issue of Clinical Epigenetics , the official ... conducted in collaboration with Lund University, ... Andersson , MD, PhD, Professor of Surgery and Vice-Dean, Faculty ...
(Date:10/12/2015)... Seattle WA (PRWEB) , ... October 12, 2015 , ... ... for the treatment of retinal diseases that can safely and chronically be administered as ... Global Health Impact Forum co-hosted by The Cleveland Clinic and taking place October 25th ...
Breaking Biology Technology: